World's Best Scientists 2026 revealed!
Claude Perreault

Claude Perreault

D-Index & Metrics

Immunology

D-Index
63
Citations
10560
World Ranking
3075
National Ranking
72

Claude Perreault publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Claude Perreault sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 268 publications — 56th percentile

56% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Claude Perreault D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Claude Perreault sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 63 D-Index — 40th percentile

40% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Claude Perreault is affiliated with the University of Montreal in Canada. Their research spans multiple fields including Immunology and Microbiology, Biochemistry, Genetics and Molecular Biology, and Medicine. The subfields of study closely linked to their work comprise Immunology, Molecular Biology, Oncology, Radiology, Nuclear Medicine and Imaging, and Hematology.

The primary research topics addressed by Claude Perreault include:

  • Immunotherapy and Immune Responses
  • Vaccines and Immunoinformatics Approaches
  • Immune Cell Function and Interaction
  • T-cell and B-cell Immunology
  • Cancer Immunotherapy and Biomarkers
  • Peptidase Inhibition and Analysis
  • CAR-T Cell Therapy Research

The frequent publication venues where Claude Perreault has contributed significantly include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cell Reports
  • Cancer Immunology Research
  • The Journal of Immunology
  • Cancer Research

Among recent published papers authored or co-authored by Claude Perreault are:

  • "Most non-canonical proteins uniquely populate the proteome or immunopeptidome," 2021, Cell Reports
  • "Atypical acute myeloid leukemia-specific transcripts generate shared and immunogenic MHC class-I-associated epitopes," 2021, Immunity
  • "Beneficial autoimmunity improves cancer prognosis," 2021, Nature Reviews Clinical Oncology
  • "The Origin and Immune Recognition of Tumor-Specific Antigens," 2020, Cancers
  • "Proteogenomics Uncovers a Vast Repertoire of Shared Tumor-Specific Antigens in Ovarian Cancer," 2020, Cancer Immunology Research

Claude Perreault collaborates frequently with several researchers, including:

  • Pierre Thibault
  • Chantal Durette
  • Marie-Pierre Hardy
  • Joël Lanoix
  • Jean-Philippe Laverdure

Best Publications

  • BamQuery: A new proteogenomic tool to explore the immunopeptidome and validate tumor‐specific antigens

    Maria Virginia Ruiz;Anca Apavaloaei;Qingchuan Zhao;Marie-Pierre Hardy

  • Noncoding regions are the main source of targetable tumor-specific antigens

    Céline M. Laumont;Krystel Vincent;Leslie Hesnard;Éric Audemard

  • Development of a highly polymorphic STR marker for identity testing purposes at the human androgen receptor gene (HUMARA).

    Danielle Desmarais;Yixi Zhong;Ranajit Chakraborty;Claude Perreault

  • A comprehensive map of the mTOR signaling network.

    Etienne Caron;Samik Ghosh;Yukiko Matsuoka;Dariel Ashton‐Beaucage

  • Global proteogenomic analysis of human MHC class I-associated peptides derived from non-canonical reading frames.

    Céline M. Laumont;Tariq Daouda;Jean-Philippe Laverdure;Éric Bonneil

  • MHC class I–associated peptides derive from selective regions of the human genome

    Hillary Pearson;Tariq Daouda;Diana Paola Granados;Chantal Durette

  • The MHC class I peptide repertoire is molded by the transcriptome

    Marie-Hélène Fortier;Étienne Caron;Marie-Pierre Hardy;Grégory Voisin

  • The 20S proteasome core, active within apoptotic exosome-like vesicles, induces autoantibody production and accelerates rejection

    Mélanie Dieudé;Christina Bell;Julie Turgeon;Deborah Beillevaire

  • Adoptive transfer of minor histocompatibility antigen-specific T lymphocytes eradicates leukemia cells without causing graft-versus-host disease

    Pierre Fontaine;Guillaume Roy-Proulx;Laurent Knafo;Chantal Baron

  • Most non-canonical proteins uniquely populate the proteome or immunopeptidome.

    Maria Virginia Ruiz Cuevas;Marie-Pierre Hardy;Jaroslav Hollý;Éric Bonneil

  • Minor histocompatibility antigens

    C Perreault;F Decary;S Brochu;M Gyger

  • ER stress affects processing of MHC class I-associated peptides

    Diana P Granados;Pierre-Luc Tanguay;Marie-Pierre Hardy;Étienne Caron

  • A granulocyte-macrophage colony–stimulating factor and interleukin-15 fusokine induces a regulatory B cell population with immune suppressive properties

    Moutih Rafei;Jeremy Hsieh;Simone Zehntner;Simone Zehntner;MengYang Li

  • Modeling T-cell acute lymphoblastic leukemia induced by the SCL and LMO1 oncogenes

    Mathieu Tremblay;Cédric S. Tremblay;Sabine Herblot;Peter D. Aplan

  • The MHC I immunopeptidome conveys to the cell surface an integrative view of cellular regulation.

    Etienne Caron;Krystel Vincent;Marie-Hélène Fortier;Jean-Philippe Laverdure

  • The SysteMHC Atlas project.

    Wenguang Shao;Patrick G.A. Pedrioli;Witold Wolski;Cristian Scurtescu

  • Exploiting non-canonical translation to identify new targets for T cell-based cancer immunotherapy.

    Céline M. Laumont;Claude Perreault;Claude Perreault

  • Prediction of graft-versus-host disease in humans by donor gene-expression profiling.

    Chantal Baron;Roland Somogyi;Larry D Greller;Vincent Rineau

  • Study of Langerhans cells after allogeneic bone marrow transplantation.

    Claude Perreault;Micheline Pelletier;Diane Landry;Martin Gyger

  • Impact of genomic polymorphisms on the repertoire of human MHC class I-associated peptides

    Diana Paola Granados;Dev Sriranganadane;Tariq Daouda;Antoine Zieger

  • Evidence for adequate thymic function but impaired naive T-cell survival following allogeneic hematopoietic stem cell transplantation in the absence of chronic graft-versus-host disease

    Jean-François Poulin;Myriam Sylvestre;Patrick Champagne;Marie-Lise Dion

  • Most Non-Canonical Proteins Uniquely Populate the Proteome or Immunopeptidome

    Maria Virginia Ruiz Cuevas;Marie-Pierre Hardy;Jaroslav Holly;Éric Bonneil

Frequent Co-Authors

Pierre Thibault
Pierre Thibault University of Montreal
Guy Sauvageau
Guy Sauvageau University of Montreal
Jacques Galipeau
Jacques Galipeau University of Wisconsin–Madison
Yoshua Bengio
Yoshua Bengio University of Montreal
Seppo Vainio
Seppo Vainio University of Oulu
Guido Kroemer
Guido Kroemer Université Paris Cité
Jerome Ritz
Jerome Ritz Harvard University
János G. Filep
János G. Filep University of Montreal
Derry C. Roopenian
Derry C. Roopenian The Jackson Laboratory
Sylvie Mader
Sylvie Mader University of Montreal

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare fields can open diverse career opportunities. Nursing, in particular, offers several flexible online pathways that complement immunology knowledge. One great option for beginners is online nursing programs for non nurses, which allow students without prior nursing experience to enter this rewarding field and gain essential clinical skills.

If you're looking to accelerate your education, consider the 12-month accelerated nursing programs. These intensive courses are designed for students with prior degrees and aim to fast-track them into nursing roles, enabling a quicker transition into healthcare careers where immunology expertise is valuable.

For a more entry-level nursing route, lpn schools easy to get into provide accessible options to quickly start working in patient care. Licensed Practical Nurses often collaborate with immunologists, especially in settings involving immunotherapy or infection control.

Advancing further, many professionals pursue nurse practitioner roles. Understanding what is the easiest np program can help determine the best path to specialize in areas like immunology-related care or chronic disease management, enhancing career growth and expertise.

Best Scientists Citing Claude Perreault

Trending Scientists

Recently Published Articles